{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:55:52Z","timestamp":1791572152327,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.arr.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T12:17:29Z","timestamp":1384604249000},"page":"10-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis"],"prefix":"10.1016","volume":"13","author":[{"given":"Michaela A.","family":"Castello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2013.10.001_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrd3842-c1","article-title":"Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease","volume":"12","author":"Aisen","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2013.10.001_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-5-36","article-title":"Increased expression of RXR\u03b1 in dementia: an early harbinger for the cholesterol dyshomeostasis?","volume":"5","author":"Akram","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2013.10.001_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"Alzheimer's Association","year":"2013","journal-title":"Alzheimers Dement.: J. Alzheimers Assoc."},{"key":"10.1016\/j.arr.2013.10.001_bib0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2013.10.001_bib0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2013.10.001_bib0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer's pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.arr.2013.10.001_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-2009-1151","article-title":"Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta","volume":"18","author":"Castellani","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2013.10.001_bib0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2885","article-title":"Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is too big to fail","volume":"224","author":"Castellani","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.arr.2013.10.001_bib0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.arr.2012.06.007","article-title":"Rational heterodoxy: cholesterol reformation of the amyloid doctrine","volume":"12","author":"Castello","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2013.10.001_bib0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2013.10.001_bib0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.arr.2013.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/acel.12002","article-title":"Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice","volume":"11","author":"Currais","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2013.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2013.10.001_bib0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","article-title":"Anti-a\u03b2 therapeutics in Alzheimer's disease: the need for a paradigm shift","volume":"69","author":"Golde","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2013.10.001_bib0075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1042\/BST0390920","article-title":"The amyloid cascade hypothesis has misled the pharmaceutical industry","volume":"39","author":"Hardy","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.arr.2013.10.001_bib0080","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1523\/JNEUROSCI.4872-08.2009","article-title":"Interaction of reelin with amyloid precursor protein promotes neurite outgrowth","volume":"29","author":"Hoe","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2013.10.001_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1 CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2013.10.001_bib0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST0390891","article-title":"Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease","volume":"39","author":"H\u00f6lscher","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.arr.2013.10.001_bib0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","article-title":"Copernicus revisited: amyloid beta in Alzheimer's disease","volume":"22","author":"Joseph","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2013.10.001_bib0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2013.10.001_bib0105","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/brain\/awr286","article-title":"Tau elevations in the brain extracellular space correlate with reduced amyloid-\u03b2 levels and predict adverse clinical outcomes after severe traumatic brain injury","volume":"135","author":"Magnoni","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.arr.2013.10.001_bib0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrd3842","article-title":"Sting of Alzheimer's failures offset by upcoming prevention trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2013.10.001_bib0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2013.10.001_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2011.01.028","article-title":"Loss of amyloid precursor protein in a mouse model of Niemann\u2013Pick type C disease exacerbates its phenotype and disrupts tau homeostasis","volume":"42","author":"Nunes","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2013.10.001_bib0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.57.2.226","article-title":"Accuracy of clinical criteria for AD in the Honolulu\u2013Asia Aging Study, a population-based study","volume":"57","author":"Petrovitch","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2013.10.001_bib0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12035-012-8360-z","article-title":"Brain ischemia activates \u03b2- and \u03b3-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease","volume":"47","author":"Pluta","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2013.10.001_bib0135","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2013.10.001_bib0140","doi-asserted-by":"crossref","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2013.10.001_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn3151","article-title":"Recruiting adaptive cellular stress responses for successful brain ageing","volume":"13","author":"Stranahan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2013.10.001_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fneur.2013.00079","article-title":"Amyloid-\u03b2 peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: a review of experimental and clinical studies","volume":"4","author":"Tsitsopoulos","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2013.10.001_bib0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163713000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163713000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:15:27Z","timestamp":1788246927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163713000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"alternative-id":["S1568163713000688"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2013.10.001","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}